Takings issues in the approval of generic biologics

被引：0

作者：

Yoo, JC ^{[1
]}

机构：

[1] Univ Calif Berkeley, Boalt Hall Sch Law, Berkeley, CA 94720 USA

来源：

FOOD AND DRUG LAW JOURNAL | 2005年 / 60卷 / 01期

关键词：

D O I：

暂无

中图分类号：

TS2 [食品工业];

学科分类号：

0832 ;

摘要：

引用

页码：33 / 43

页数：11

共 50 条

[31] COUNCIL ACTS ON BIOLOGICS ISSUES
RAEF, TA
JOURNAL OF THE AMERICAN VETERINARY MEDICAL ASSOCIATION, 1990, 196 (10) : 1567 - 1567
[32] BIOLOGICS AND SAFETY ISSUES GUIDELINE
Holroyd, Christopher R.
RHEUMATOLOGY, 2017, 56 : 9 - 9
[33] Interplay between FDA approval and patenting of drugs and biologics
Bigornia, Luisa
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2012, 243
[34] Senators draft legislation for follow-on biologics approval
Pharm. Technol., 2007, 8 (22):
[35] US Food and Drug Administration approval of generic versions of complex biologics: implications for the practicing physician using low molecular weight heparins
Cohen, Marc
Jeske, Walter P.
Nicolau, Jose C.
Montalescot, Gilles
Fareed, Jawed
JOURNAL OF THROMBOSIS AND THROMBOLYSIS, 2012, 33 (03) : 230 - 238
[36] US Food and Drug Administration approval of generic versions of complex biologics: implications for the practicing physician using low molecular weight heparins
Marc Cohen
Walter P. Jeske
Jose C. Nicolau
Gilles Montalescot
Jawed Fareed
Journal of Thrombosis and Thrombolysis, 2012, 33 : 230 - 238
[37] Blockbusters for Cheap? The Difficulties Surrounding Generic Biologics
Josephson, S. Andrew
Johnston, S. Claiborne
Hauser, Stephen L.
ANNALS OF NEUROLOGY, 2013, 74 (03) : A7 - A8
[38] Generic biologics may need more data
不详
ATLA-ALTERNATIVES TO LABORATORY ANIMALS, 2007, 35 (03): : 299 - 299
[39] US biotech prepares to fight generic biologics
Brian Reid
Nature Biotechnology, 2002, 20 : 322 - 322
[40] Orphan Drugs: The Potential Impact of Generic Biologics
Nair, Kavita V.
AMERICAN HEALTH AND DRUG BENEFITS, 2010, 3 (01): : 22 - 23

← 1 2 3 4 5 →